Nektar Therapeutics Reports Fourth Quarter and Year-End 2020 Financial Results
Go back to Nektar Therapeutics Reports Fourth Quarter and Year-End 2020 Financial Results| Nektar Therapeutics (NASDAQ: NKTR) | Delayed: 67.75 +0.91 (1.36%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $66.84 | 52 Week High | $19.98 | |||
| Open | $67.08 | 52 Week Low | $10.52 | |||
| Day High | $68.00 | P/E | N/A | |||
| Day Low | $66.25 | EPS | $-1.45 | |||
| Volume | 58,783 | |||||
